These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 22527202

  • 1. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
    Thambiah S, Roplekar R, Manghat P, Fogelman I, Fraser WD, Goldsmith D, Hampson G.
    Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
    [Abstract] [Full Text] [Related]

  • 2. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G, Edwards S, Conroy S, Blake GM, Fogelman I, Frost ML.
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [Abstract] [Full Text] [Related]

  • 3. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.
    Behets GJ, Viaene L, Meijers B, Blocki F, Brandenburg VM, Verhulst A, D'Haese PC, Evenepoel P.
    PLoS One; 2017 Sep; 12(5):e0176411. PubMed ID: 28493902
    [Abstract] [Full Text] [Related]

  • 4. Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).
    Manghat P, Souleimanova I, Cheung J, Wierzbicki AS, Harrington DJ, Shearer MJ, Chowienczyk P, Fogelman I, Nerlander M, Goldsmith D, Hampson G.
    Bone; 2011 May 01; 48(5):1127-32. PubMed ID: 21281749
    [Abstract] [Full Text] [Related]

  • 5. Sclerostin and DKK1 in primary hyperparathyroidism.
    Viapiana O, Fracassi E, Troplini S, Idolazzi L, Rossini M, Adami S, Gatti D.
    Calcif Tissue Int; 2013 Apr 01; 92(4):324-9. PubMed ID: 23430197
    [Abstract] [Full Text] [Related]

  • 6. Circulating sclerostin and dickkopf-1 levels in ossification of the posterior longitudinal ligament of the spine.
    Kashii M, Matuso Y, Sugiura T, Fujimori T, Nagamoto Y, Makino T, Kaito T, Ebina K, Iwasaki M, Yoshikawa H.
    J Bone Miner Metab; 2016 May 01; 34(3):315-24. PubMed ID: 26040409
    [Abstract] [Full Text] [Related]

  • 7. Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study.
    Hsu BG, Liou HH, Lee CJ, Chen YC, Ho GJ, Lee MC.
    Medicine (Baltimore); 2016 Apr 01; 95(15):e3300. PubMed ID: 27082570
    [Abstract] [Full Text] [Related]

  • 8. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
    Morena M, Jaussent I, Dupuy AM, Bargnoux AS, Kuster N, Chenine L, Leray-Moragues H, Klouche K, Vernhet H, Canaud B, Cristol JP.
    Nephrol Dial Transplant; 2015 Aug 01; 30(8):1345-56. PubMed ID: 25854266
    [Abstract] [Full Text] [Related]

  • 9. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
    Voskaridou E, Christoulas D, Plata E, Bratengeier C, Anastasilakis AD, Komninaka V, Kaliontzi D, Gkotzamanidou M, Polyzos SA, Dimopoulou M, Terpos E.
    Horm Metab Res; 2012 Nov 01; 44(12):909-13. PubMed ID: 22581647
    [Abstract] [Full Text] [Related]

  • 10. Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover.
    Gifre L, Ruiz-Gaspà S, Monegal A, Nomdedeu B, Filella X, Guañabens N, Peris P.
    Bone; 2013 Nov 01; 57(1):272-6. PubMed ID: 23981659
    [Abstract] [Full Text] [Related]

  • 11. Circulating Levels of Dickkopf-Related Protein 1 Decrease as Measured GFR Declines and Are Associated with PTH Levels.
    Forster CM, White CA, Turner ME, Norman PA, Ward EC, Hopman WM, Adams MA, Holden RM.
    Am J Nephrol; 2020 Nov 01; 51(11):871-880. PubMed ID: 33238271
    [Abstract] [Full Text] [Related]

  • 12. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG.
    Nephrol Dial Transplant; 2008 Feb 01; 23(2):586-93. PubMed ID: 17933842
    [Abstract] [Full Text] [Related]

  • 13. Sclerostin and DKK1: new players in renal bone and vascular disease.
    Evenepoel P, D'Haese P, Brandenburg V.
    Kidney Int; 2015 Aug 01; 88(2):235-40. PubMed ID: 26083653
    [Abstract] [Full Text] [Related]

  • 14. Sclerostin: Another vascular calcification inhibitor?
    Claes KJ, Viaene L, Heye S, Meijers B, d'Haese P, Evenepoel P.
    J Clin Endocrinol Metab; 2013 Aug 01; 98(8):3221-8. PubMed ID: 23788689
    [Abstract] [Full Text] [Related]

  • 15. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
    Cejka D, Jäger-Lansky A, Kieweg H, Weber M, Bieglmayer C, Haider DG, Diarra D, Patsch JM, Kainberger F, Bohle B, Haas M.
    Nephrol Dial Transplant; 2012 Jan 01; 27(1):226-30. PubMed ID: 21613383
    [Abstract] [Full Text] [Related]

  • 16. Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.
    Rossini M, Viapiana O, Idolazzi L, Ghellere F, Fracassi E, Troplini S, Povino MR, Kunnathully V, Adami S, Gatti D.
    Calcif Tissue Int; 2016 May 01; 98(5):438-45. PubMed ID: 26645432
    [Abstract] [Full Text] [Related]

  • 17. Analysis of association of LRP5, LRP6, SOST, DKK1, and CTNNB1 genes with bone mineral density in a Slovenian population.
    Mencej-Bedrac S, Prezelj J, Kocjan T, Komadina R, Marc J.
    Calcif Tissue Int; 2009 Dec 01; 85(6):501-6. PubMed ID: 19898734
    [Abstract] [Full Text] [Related]

  • 18. Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study.
    Dellegrottaglie S, Sands RL, Gillespie BW, Gnanasekaran G, Zannad F, Sengstock D, Finkelstein F, Kiser M, Eisele G, Hinderliter AL, Levin NW, Cattan V, Saran R, Rajagopalan S.
    Nephrol Dial Transplant; 2011 Sep 01; 26(9):2891-8. PubMed ID: 21562144
    [Abstract] [Full Text] [Related]

  • 19. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study.
    Yang HY, Wu DA, Chen MC, Hsu BG.
    Diab Vasc Dis Res; 2019 May 01; 16(3):281-288. PubMed ID: 30547685
    [Abstract] [Full Text] [Related]

  • 20. Disturbances of Wnt/β-catenin pathway and energy metabolism in early CKD: effect of phosphate binders.
    de Oliveira RB, Graciolli FG, dos Reis LM, Cancela AL, Cuppari L, Canziani ME, Carvalho AB, Jorgetti V, Moysés RM.
    Nephrol Dial Transplant; 2013 Oct 01; 28(10):2510-7. PubMed ID: 23975746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.